Repligen Reports Second Quarter 2022 Financial Results and Raises Full Year 2022 Financial Guidance

Go back to Repligen Reports Second Quarter 2022 Financial Results and Raises Full Year 2022 Financial Guidance
Repligen Corp (NASDAQ: RGEN) Delayed: 126.57 -5.45 (4.13%)
Previous Close $132.02    52 Week High $33.79 
Open $131.13    52 Week Low $20.07 
Day High $133.74    P/E 180.81 
Day Low $125.44    EPS $0.70 
Volume 865,912